Regular monitoring and treating to a DAS-28 score of less than 2.6 produces better RA outcomes than not monitoring DAS-28 or the HAQ-Disability Index score. Medscape Medical News
Highlights from the American College of Rheumatology 2007 meeting on advances in the pharmacologic management of rheumatoid arthritis. Medscape Rheumatology
In combination with methotrexate, tocilizumab, an IL-6 receptor inhibitor, can safely improve the signs and symptoms of rheumatoid arthritis in patients with an inadequate response to anti-tumor necrosis factor (TNF) biologicals, new research shows. Reuters Health Information
A summary by Maxime Dougados, MD, of current data on the management of rheumatoid arthritis in patients with cardiovascular disease, as presented at EULAR 2008. Medscape Rheumatology
How promising are biologic therapies in the treatment of systemic lupus erythematosus? This study takes an in-depth look at belimumab. International Journal of Clinical Rheumatology